Curcumin inhibits HMGB1 releasing and attenuates concanavalin A-induced hepatitis in mice

European Journal of Pharmacology

Volumn 697, Issue 1-3, 2012, Pages 152-157

  Wang, Chao ^a   Nie, Hao ^a   Li, Kan ^a   Zhang, Yan Xiang ^a   Yang, Fei ^a   Li, Cheng Bin ^b   Wang, Chang Fu ^b   Gong, Quan ^a  

^a YANGTZE UNIVERSITY   (China)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Concanavalin A; Curcumin; Hepatic injury; HMGB1

Indexed keywords

ALANINE AMINOTRANSFERASE; CONCANAVALIN A; CURCUMIN; GAMMA INTERFERON; HIGH MOBILITY GROUP B1 PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ACUTE DISEASE; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; DRUG MECHANISM; HEPATITIS; HISTOPATHOLOGY; LIVER CELL; LIVER INJURY; LIVER NECROSIS; LIVER PROTECTION; MALE; MORTALITY; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN SECRETION;

ALANINE TRANSAMINASE; ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTIOXIDANTS; APOPTOSIS; BIOLOGICAL MARKERS; CONCANAVALIN A; CURCUMIN; CYTOPROTECTION; DISEASE MODELS, ANIMAL; DOWN-REGULATION; HEPATITIS, AUTOIMMUNE; HMGB1 PROTEIN; INTERFERON-GAMMA; LIVER; MALE; MALONDIALDEHYDE; MICE; MICE, INBRED C57BL; NECROSIS; OXIDATIVE STRESS; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84869487480     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2012.09.050     Document Type: Article

References (35)

1. B.B. Aggarwal, and K.B. Harikumar Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases Int. J. Biochem. Cell Biol. 41 2009 40 59
2. U. Andersson, and K.J. Tracey HMGB1 is a therapeutic target for sterile inflammation and infection Annu. Rev. Immunol. 29 2011 139 162
3. R.A. DeMarco, M.P. Fink, and M.T. Lotze Monocytes promote natural killer cell interferon gamma production in response to the endogenous danger signal HMGB1 Mol. Immunol. 42 2005 433 444
4. D. Feng, Y. Mei, Y. Wang, B. Zhang, C. Wang, and L. Xu Tetrandrine protects mice from concanavalin A-induced hepatitis through inhibiting NF-kappaB activation Immunol. Lett. 121 2008 127 133
5. F. Gantner, M. Leist, A.W. Lohse, P.G. Germann, and G. Tiegs Concanavalin A-induced T-cell-mediated hepatic injury in mice: the role of tumor necrosis factor Hepatology 21 1995 190 198
6. Q. Gong, H. Zhang, J.H. Li, L.H. Duan, S. Zhong, X.L. Kong, F. Zheng, Z. Tan, P. Xiong, G. Chen, M. Fang, and F.L. Gong High-mobility group box 1 exacerbates concanavalin A-induced hepatic injury in mice J. Mol. Med. 88 2010 1289 1298
7. O.W. Griffith Determination of glutathione and glutathione disulfide using glutathione reductase and 2-vinylpyridine Anal. Biochem. 106 1980 207 212
8. 3 against Con A-induced mouse hepatitis through promoting vitamin D receptor gene expression Acta. Pharmacol. Sin. 31 2010 703 708
9. D.C. Kim, W. Lee, and J.S. Bae Vascular anti-inflammatory effects of curcumin on HMGB1-mediated responses in vitro Inflamm. Res. 60 2011 1161 1168
10. S. Kusters, F. Gantner, G. Kunstle, and G. Tiegs Interferon gamma plays a critical role in T cell-dependent liver injury in mice initiated by concanavalin A Gastroenterology 111 1996 462 471
11. D.J. Messner, G. Sivam, and K.V. Kowdley Curcumin reduces the toxic effects of iron loading in rat liver epithelial cells Liver Int. 29 2009 63 72
12. Y. Miyazawa, H. Tsutsui, H. Mizuhara, H. Fujiwara, and K. Kaneda Involvement of intrasinusoidal hemostasis in the development of concanavalin A-induced hepatic injury in mice Hepatology 27 1998 497 506
13. S. Müller, L. Ronfani, and M.E. Bianchi Regulated expression and subcellular localization of HMGB1, a chromatin protein with a cytokine function J. Intern. Med. 255 2004 332 343
14. K. Nakamura, M. Okada, M. Yoneda, S. Takamoto, Y. Nakade, K. Tamori, K. Aso, and I. Makino Macrophage inflammatory protein-2 induced by TNF-alpha plays a pivotal role in concanavalin A-induced liver injury in mice J. Hepatol. 35 2001 217 224
15. T. Ostberg, H. Wähämaa, K. Palmblad, N. Ito, P. Stridh, M. Shoshan, M.T. Lotze, H.E. Harris, and U. Andersson Oxaliplatin retains HMGB1 intranuclearly and ameliorates collagen type II-induced arthritis Arthritis. Res. Ther. 10 2008 R1
16. L. Pari, D. Tewas, and J. Eckel Role of curcumin in health and disease Arch. Physiol. Biochem. 114 2008 127 149
17. J.S. Park, D. Svetkauskaite, Q. He, J.Y. Kim, D. Strassheim, A. Ishizaka, and E. Abraham Involvement of toll-like receptors 2 and 4 in cellular activation by high mobility group box 1 protein J. Biol. Chem. 279 2004 7370 7377
18. V. Rajakrishnan, A. Jayadeep, O.S. Arun, P.R. Sudhakaran, and V.P. Menon Changes in the prostaglandin levels in alcohol toxicity: effect of curcumin and N-acetylcysteine J. Nutr. Biochem. 11 2000 509 514
19. K. Reyes-Gordillo, J. Segovia, M. Shibayama, V. Tsutsumi, P. Vergara, M.G. Moreno, and P. Muriel Curcumin prevents and reverses cirrhosis induced by bile duct obstruction or CCl4 in rats: role of TGF-beta modulation and oxidative stress Fundam. Clin. Pharmacol. 22 2008 417 427
20. G. Sass, S. Heinlein, A. Agli, R. Bang, J. Schumann, and G. Tiegs Cytokine expression in three mouse models of experimental hepatitis Cytokine 19 2002 115 120
21. P. Scaffidi, T. Misteli, and ME. Bianchi Release of chromatin protein HMGB1 by necrotic cells triggers inflammation Nature 418 2002 191 195
22. R.A. Sharma, A.J. Gescher, and W.P. Steward Curcumin: the story so far Eur. J. Cancer 41 2005 1955 1968
23. G.P. Sims, D.C. Rowe, S.T. Rietdijk, R. Herbst, and A.J. Coyle HMGB1 and RAGE in inflammation and cancer Annu. Rev. Immunol. 28 2010 367 388
24. + T cell- and STAT3-dependent manners J. Immunol. 172 2004 5648 5655
25. Y. Tagawa, K. Sekikawa, and Y. Iwakura Suppression of concanavalin A-induced hepatitis in IFN-gamma(-/-) mice, but not in TNF-alpha(-/-) mice: role for IFN-gamma in activating apoptosis of hepatocytes J. Immunol. 159 1997 1418 1428
26. K. Takeda, Y. Hayakawa, L. Van Kaer, H. Matsuda, H. Yagita, and K. Okumura Critical contribution of liver natural killer T cells to a murine model of hepatitis Proc. Natl. Acad. Sci. U.S.A. 97 2000 5498 5503
27. M. Tamaru, K. Nishioji, Y. Kobayashi, Y. Watanabe, Y. Itoh, T. Okanoue, M. Murai, K. Matsushima, and S. Narumi Liver-infiltrating T lymphocytes are attracted selectively by IFN-inducible protein-10 Cytokine 12 2000 299 308
28. G. Tiegs, J. Hentschel, and A. Wendel A T cell-dependent experimental liver injury in mice inducible by concanavalin A J. Clin. Invest. 90 1992 196 203
29. C. Trautwein, T. Rakemann, D.A. Brenner, K. Streetz, L. Licato, M.P. Manns, and G. Tiegs Concanavalin A-induced liver cell damage: activation of intracellular pathways triggered by tumor necrosis factor in mice Gastroenterology 114 1998 1035 1045
30. C.T. Tu, B. Han, H.C. Liu, and S.C. Zhang Curcumin protects mice against concanavalin A-induced hepatitis by inhibiting intrahepatic intercellular adhesion molecule-1 (ICAM-1) and CXCL10 expression Mol. Cell. Biochem. 358 2011 53 60
31. H. Wang, O. Bloom, M. Zhang, J.M. Vishnubhakat, M. Ombrellino, J. Che, A. Frazier, H. Yang, S. Ivanova, L. Borovikova, K.R. Manogue, E. Faist, E. Abraham, J. Andersson, U. Andersson, P.E. Molina, N.N. Abumrad, A. Sama, and K.J. Tracey HMGB1 as a late mediator of endotoxin lethality in mice Science 285 1999 248 251
32. E.D. Will Mechanism of lipid peroxide formation in animal tissues Biochem. J. 99 1966 667 676
33. D. Wolf, R. Hallmann, G. Sass, M. Sixt, S. Küsters, B. Fregien, C. Trautwein, and G. Tiegs TNF-alpha-induced expression of adhesion molecules in the liver is under the control of TNFR1-relevance for concanavalin A-induced hepatitis J. Immunol. 166 2001 1300 1307
34. S.F. Yan, R. Ramasamy, L.G. Bucciarelli, T. Wendt, L.K. Lee, B.I. Hudson, D.M. Stern, E. Lalla, S.D. Yan, L.L. Rong, Y. Naka, and A.M. Schmidt RAGE and its ligands: a lasting memory in diabetic complications? Diab. Vasc. Dis. Res. 1 2004 10 20
35. H. Yang, M. Ochani, J.H. Li, X. Qiang, M. Tanovic, H.E. Harris, S.M. Susarla, L. Ulloa, H. Wang, R. DiRaimo, C.J. Czura, H. Wang, J. Roth, H.S. Warren, M.P. Fink, M.J. Fenton, U. Andersson, and K.J. Tracey Reversing established sepsis with antagonists of endogenous high-mobility group box 1 Proc. Natl. Acad. Sci. U.S.A. 101 2004 296 301